CDC27P2

Across TCGA pan-cancer cohorts, CDC27P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CDC27P2’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where CDC27P2 RNA is repressed in tumor relative to normal tissue. In most cancer types CDC27P2 is over-expressed in tumor, although a few such as ESCA show the opposite, repressed pattern.

ESCA, LUSC, and LUAD are the cancer types where CDC27P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDC27P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	−0.035	.019	2	view →
LUSC	Male	III,IV	+0.035	.025	1	view →
LUAD	Female	All	+0.015	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CDC27P2–ESCA

Open the ESCA breakdown →